ATYR
aTyr Pharma, Inc.
0.3376$
-10.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | – | 100.0% | – | – | – | – | – | 100.0% | – | – | – | 100.0% | |
| 281.3% | – | 327.7% | – | – | – | – | – | 11,647.4% | – | – | – | – | |
| -181.3% | – | 100.0% | – | – | – | – | – | -11,547.4% | – | – | – | – | |
| 2,923.2% | – | 5,686.8% | – | – | – | – | – | 11,647.4% | – | – | – | 24,782.1% | |
| 750.4% | – | 1,492.3% | – | – | – | – | – | 2,528.9% | – | – | – | 8,927.4% | |
| 3,392.4% | – | 7,179.1% | – | – | – | – | – | 2,528.9% | – | – | – | 21,854.7% | |
| -3,573.7% | – | -7,079.1% | – | – | – | – | – | -14,076.3% | – | – | – | -33,609.5% | |
| -3,213.0% | – | -6,590.2% | – | – | – | – | – | -13,550.5% | – | – | – | -32,005.3% | |
| -0.6% | – | 1.7% | – | – | – | – | – | – | – | – | – | – | |
| -3,212.5% | – | -6,591.9% | – | – | – | – | – | -13,549.5% | – | – | – | -32,003.7% | |
| -2,931.7% | – | -6,262.6% | – | – | – | – | – | -13,463.7% | – | – | – | -30,812.6% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.